Technical information
Manufacturer
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Presentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
sLYVDkddHGTgWh7T